OTCMKTS:OSIR Osiris Therapeutics (OSIR) Stock Price, News & Analysis → The Gold Grab of the Century (From Colonial Metals) (Ad) Free OSIR Stock Alerts $18.99 0.00 (0.00%) (As of 04/17/2019) Add Compare Share Share Today's Range$18.99▼$18.9950-Day Range$18.99▼$18.9952-Week Range$7.01▼$19.30VolumeN/AAverage Volume205,753 shsMarket Capitalization$655.69 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Osiris Therapeutics alerts: Email Address Ad Colonial MetalsThe asset beating inflation by 4x"Trump Loophole" Beats Inflation? Inflation has been out of control for years. Forcing you to work longer and harder for more money that is worth less. By using the "Trump Loophole", you can use a special retirement account to buy gold — and other precious metals — without taxes or penalties.That's why we have released our Free Precious Metals Investment Guide that explains all the details About Osiris Therapeutics Stock (OTCMKTS:OSIR)Osiris Therapeutics, Inc. researches, develops, manufactures, markets, and distributes regenerative medicine products in the United States. Its products include Grafix and Stravix for treating chronic wounds of diabetic foot ulcers, venous leg ulcers, pressure ulcers, arterial ulcers, and severe burns, as well as surgical and trauma wounds; BIO4 for bone repair and regeneration in spine, trauma, extremity, cranial, and foot and ankle surgeries; and Cartiform for treating articular cartilage lesions in the knee and other joints. The company also develops and markets Menvivo for the repair of meniscus; and TruSkin for treating chronic wounds. It markets and distributes its products directly to physicians, hospitals, and other healthcare providers, as well as through agents and distributors. Osiris Therapeutics, Inc. was founded in 1992 and is headquartered in Columbia, Maryland.Read More OSIR Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart OSIR Stock News HeadlinesMarch 19, 2024 | fool.comKanak KantiFebruary 18, 2024 | msn.comMIT's Albumin-based cancer vaccine shows promising results in trialsMay 5, 2024 | Colonial Metals (Ad)The asset beating inflation by 4x"Trump Loophole" Beats Inflation? Inflation has been out of control for years. Forcing you to work longer and harder for more money that is worth less. By using the "Trump Loophole", you can use a special retirement account to buy gold — and other precious metals — without taxes or penalties.February 2, 2024 | finance.yahoo.comTissue Engineering Market Set to Soar Past USD 32.45 Billion by 2030January 19, 2024 | finance.yahoo.comAnti-biofilm Wound Dressing Market Size & Share to Surpass US$ 2.3 Billion by 2030 - Exclusive Report by Persistence Market ResearchDecember 29, 2023 | nypost.comNASA launches mission to intercept ‘God of Chaos’ asteroid as it nears Earth’s orbitDecember 11, 2023 | markets.businessinsider.comImmunOs Therapeutics Presents Details of Novel Bispecific Anti-Tumor Molecules at ESMO Immuno-Oncology Congress 2023December 7, 2023 | msn.comIce Age ‘writing system’ to ‘zombie worm’ — 10 biggest science headlines of 2023May 5, 2024 | Colonial Metals (Ad)The asset beating inflation by 4x"Trump Loophole" Beats Inflation? Inflation has been out of control for years. Forcing you to work longer and harder for more money that is worth less. By using the "Trump Loophole", you can use a special retirement account to buy gold — and other precious metals — without taxes or penalties.October 25, 2023 | finance.yahoo.comUNION therapeutics to present at 7th Annual Dermatology Drug Development Summit in BostonOctober 12, 2023 | uk.finance.yahoo.comCoave Therapeutics appoints Leading World Experts to newly formed Scientific Advisory Board dedicated to its Genetic Medicine Delivery PlatformOctober 11, 2023 | finance.yahoo.comWatch NASA reveal its Bennu asteroid samples at 11AM ETOctober 6, 2023 | finance.yahoo.comUNION therapeutics announces presentation of new data on orismilast at the EADV Congress 2023September 28, 2023 | msn.comSuspect shot by police on East Tabor Avenue in FairfieldSeptember 12, 2023 | bizjournals.com10 companies selected as finalists for Coolest Thing Made in Colorado contestSeptember 12, 2023 | msn.comFinalists announced for ‘Coolest Thing Made In Colorado’ competitionSeptember 12, 2023 | msn.comFinalists announced for ‘Coolest Thing Made In Colorado’July 25, 2023 | finance.yahoo.comAmniotic Membrane Global Market Report 2023July 25, 2023 | benzinga.comRegenerative Medicine Market to Grow Rapidly at a CAGR of 21.6% by 2030 | DataM IntelligenceJune 23, 2023 | marketwatch.comUS Cell & Gene Therapy Market Report 2023-2028: Industry Expected to Grow at a CAGR of 41.25% - ResearchAndMarkets.comJune 16, 2023 | benzinga.comRegenerative Medicine Market is expected to grow at a tremendous CAGR of 22.8% during the forecast period 2023-2030May 30, 2023 | finance.yahoo.comTissue Engineering Global Market Report 2023May 23, 2023 | finance.yahoo.comGlobal Cell Therapy Market Report 2023: Growing Approvals for Cell-based Therapies Fuels the SectorMay 22, 2023 | markets.businessinsider.comVesselon Discovery Protects and Expands Drug FranchisesMay 17, 2023 | marketwatch.comBiological Derived Devices Market Reports, Scope, Methodology, Timelines And Challenges Forecast Till 2030May 17, 2023 | marketwatch.comAllogeneic Stem Cells Market Research Report Analysis the Regions, and International Markets Forecast (2023-2030)May 17, 2023 | marketwatch.comGlobal Stem Cells Market [2023-2030] | Growth Rate (CAGR) at a 10.9% | Expected to Reach Worth 5727.2See More Headlines Receive OSIR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Osiris Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Biological Products, Except Diagnostic Sub-IndustryBiotechnology Current SymbolOTCMKTS:OSIR Previous SymbolNASDAQ:OSIR CUSIP68827R10 CIK1360886 Webwww.osiristx.com Phone443-545-1800FaxN/AEmployeesN/AYear Founded1992Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares34,528,000Free FloatN/AMarket Cap$655.69 million OptionableNot Optionable BetaN/A Social Links 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report Key ExecutivesMr. Jason Keefer (Age 46)Interim Pres & CEO Dr. Alla N. Danilkovitch (Age 54)Chief Scientific Officer Mr. Joel David Rogers (Age 56)Interim Chief Financial Officer Mr. Edward YipChief Legal Officer & Corp. Sec.Mr. Laine DyessVP of SalesKey CompetitorsNovavaxNASDAQ:NVAXBioCryst PharmaceuticalsNASDAQ:BCRXAgenusNASDAQ:AGENHilleVaxNASDAQ:HLVXKyverna TherapeuticsNASDAQ:KYTXView All Competitors OSIR Stock Analysis - Frequently Asked Questions How have OSIR shares performed in 2024? Osiris Therapeutics' stock was trading at $18.99 on January 1st, 2024. Since then, OSIR stock has increased by 0.0% and is now trading at $18.99. View the best growth stocks for 2024 here. What other stocks do shareholders of Osiris Therapeutics own? Based on aggregate information from My MarketBeat watchlists, some companies that other Osiris Therapeutics investors own include Sierra Wireless (SWIR), Achillion Pharmaceuticals (ACHN), Fate Therapeutics (FATE), Ionis Pharmaceuticals (IONS), Mallinckrodt (MNK), Aerie Pharmaceuticals (AERI), Cytokinetics (CYTK) and Depomed (DEPO). How do I buy shares of Osiris Therapeutics? Shares of OSIR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:OSIR) was last updated on 5/5/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyThe asset beating inflation by 4xColonial MetalsCould Your Accounts Be Frozen?Allegiance GoldExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersMysterious Gold Leverage Just AnnouncedStansberry ResearchThe only AI company you should be looking atBehind the MarketsDid You Get Your Free Bitcoin Yet?Crypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Osiris Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.